Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Æterna_Zentaris> ?p ?o. }
Showing items 1 to 30 of
30
with 100 items per page.
- Æterna_Zentaris abstract "Æterna Zentaris Inc. is a Quebec, Canada-based biopharmaceutical drug development company focused in oncology and endocrine therapy, currently investigating treatments for various unmet medical needs. The Company's pipeline encompasses compounds at all stages of development, from drug discovery through to marketed products. It has over 80 employees in Canada, USA and Germany. The company is based in Canada, the development and research site is based in Germany. The company has 3 lead projects: an ongoing Phase 3 trial in multiple myeloma (a form of blood cancer) conducted under a Special Protocol Assessment (SPA): a Phase 3 trial in endometrial cancer with AEZS-108 expected to be initiated in 1Q 2013, and a New Drug Application (NDA) expected to be filed in 1Q 2013 for the approval of AEZS-130 as potentially the first oral diagnostic test for adult growth hormone deficiency (AGHD).Perifosine: Fast track designation and orphan drug status granted by the FDA. Orphan Medicinal Product designation and positive Scientific Advice granted by the EMA .AEZS-108: Orphan drug and Orphan medicinal product designations granted by the FDA and EMA respectively, for the treatment of ovarian cancer.AEZS-130: Orphan drug designation granted by the FDA for use as a diagnostic test for AGHD.".
- Æterna_Zentaris wikiPageID "867875".
- Æterna_Zentaris wikiPageRevisionID "603004083".
- Æterna_Zentaris homepage www.aezsinc.com.
- Æterna_Zentaris industry "Biotechnology".
- Æterna_Zentaris keyPeople "Prof. Juergen Engel, Ph.D.".
- Æterna_Zentaris locationCity Quebec.
- Æterna_Zentaris locationCountry Canada.
- Æterna_Zentaris marketCap "3.5E7".
- Æterna_Zentaris name "Æterna Zentaris Inc.".
- Æterna_Zentaris type "Public".
- Æterna_Zentaris subject Category:Biotechnology_companies_of_Canada.
- Æterna_Zentaris subject Category:Companies_based_in_Quebec_City.
- Æterna_Zentaris subject Category:Companies_listed_on_NASDAQ.
- Æterna_Zentaris subject Category:Companies_listed_on_the_Toronto_Stock_Exchange.
- Æterna_Zentaris subject Category:Pharmaceutical_companies_of_Canada.
- Æterna_Zentaris type Agent.
- Æterna_Zentaris type Company.
- Æterna_Zentaris type Organisation.
- Æterna_Zentaris type Organization.
- Æterna_Zentaris type Agent.
- Æterna_Zentaris type SocialPerson.
- Æterna_Zentaris type Thing.
- Æterna_Zentaris comment "Æterna Zentaris Inc. is a Quebec, Canada-based biopharmaceutical drug development company focused in oncology and endocrine therapy, currently investigating treatments for various unmet medical needs. The Company's pipeline encompasses compounds at all stages of development, from drug discovery through to marketed products. It has over 80 employees in Canada, USA and Germany. The company is based in Canada, the development and research site is based in Germany.".
- Æterna_Zentaris label "Æterna Zentaris".
- Æterna_Zentaris sameAs %C3%86terna_Zentaris.
- Æterna_Zentaris sameAs Q8077347.
- Æterna_Zentaris sameAs Q8077347.
- Æterna_Zentaris wasDerivedFrom Æterna_Zentaris?oldid=603004083.
- Æterna_Zentaris homepage www.aezsinc.com.